This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Australian and New Zealand Society of Clinical and Experimental Pharmacologists and Toxicologists | |
|---|---|
| Name | Australian and New Zealand Society of Clinical and Experimental Pharmacologists and Toxicologists |
| Abbreviation | ANZSCET |
| Founded | 1953 |
| Headquarters | Melbourne, Victoria, Australia |
| Region served | Australia and New Zealand |
| Fields | Clinical pharmacology; Experimental pharmacology; Toxicology |
Australian and New Zealand Society of Clinical and Experimental Pharmacologists and Toxicologists
The Australian and New Zealand Society of Clinical and Experimental Pharmacologists and Toxicologists is a regional learned society representing practitioners, researchers, and educators in clinical pharmacology and toxicology across Australia and New Zealand. The society fosters professional development, research translation, and policy engagement through conferences, publications, training programs, and partnerships with universities, hospitals, and regulatory bodies. Its membership spans clinicians, basic scientists, pharmacists, toxicologists, and allied health professionals working in academic, hospital, industry, and government settings.
The society was established in 1953 amid postwar expansion of biomedical research and hospital-based pharmacology services in cities such as Melbourne, Sydney, Auckland, and Wellington. Early figures who shaped the field included clinicians and researchers associated with institutions like Royal Melbourne Hospital, St Vincent's Hospital, Sydney, Auckland City Hospital, and university departments at University of Melbourne, University of Sydney, University of Auckland, and University of Otago. Over ensuing decades the society interacted with international organisations including British Pharmacological Society, American Society for Clinical Pharmacology and Therapeutics, and International Union of Basic and Clinical Pharmacology, contributing to curricula reform, drug monitoring systems, and toxicology services. Key milestones included establishment of formal accreditation processes, initiation of annual scientific meetings, and involvement in responses to drug safety incidents in Australia and New Zealand, alongside regulatory agencies such as the Therapeutic Goods Administration and Medsafe.
The society’s mission is to advance clinical and experimental pharmacology and toxicology for improved patient care, public safety, and scientific knowledge. Objectives encompass promoting high-quality research at institutions like Walter and Eliza Hall Institute of Medical Research and Garvan Institute of Medical Research, supporting education through partnerships with Monash University and University of Queensland, and informing policy with evidence-based advice to bodies such as the National Health and Medical Research Council and regional health ministries. The society seeks to foster links with professional colleges including the Royal Australasian College of Physicians and the Royal Australasian College of Surgeons to integrate pharmacological expertise into clinical practice.
Membership includes fellows, ordinary members, trainee members, and honorary members drawn from hospitals, universities, industry, and regulatory agencies. Notable member affiliations have included researchers from University of New South Wales, University of Otago Christchurch, Griffith University, and specialist centres such as Royal Prince Alfred Hospital and Princess Alexandra Hospital. Governance is overseen by an elected council and executive committee with roles such as president, treasurer, and secretary, with terms and election procedures modelled on comparable bodies like Australian Medical Association and New Zealand Medical Association. Subcommittees address education, scientific programs, awards, and ethics, engaging representatives from organizations such as Pharmaceutical Society of Australia and New Zealand Society of Anaesthetists.
Core activities include annual and regional scientific meetings, specialist interest group workshops, and policy briefings. Programs have incorporated clinical drug committees in hospitals like Royal Hobart Hospital and pharmacovigilance initiatives linked to regional centres of pharmacovigilance. The society runs awards and grants recognizing early-career researchers from universities including La Trobe University and Flinders University, and supports clinician-scientist fellowships aligned with funding schemes from Australian Research Council and Health Research Council of New Zealand. Outreach initiatives have engaged consumer groups such as National Heart Foundation of Australia and advocacy bodies like Cancer Council Australia.
The society oversees publication of newsletters, position statements, and proceedings from its meetings, and members commonly publish in journals including British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Toxicology Letters, and regionally focused outlets. Its flagship annual conference attracts delegates from institutions such as Johns Hopkins University, Harvard Medical School, University College London, and regional partners, featuring plenaries, symposia, and poster sessions. Conferences often include sessions on topics highlighted by international events like the World Congress of Pharmacology and collaborative symposia with societies such as the Asia Pacific Association of Medical Toxicology.
Education activities include supervised clinical pharmacology training posts, postgraduate courses, and continuing professional development accredited through entities like Australian Health Practitioner Regulation Agency and Medical Council of New Zealand. Training pathways link to university postgraduate programs at University of Sydney Medical School, specialised fellowships used by clinicians at Mater Hospital, Brisbane, and laboratory-based training in toxicology aligned with facilities at Griffith University Centre for Toxicology Research. The society runs workshops on therapeutic drug monitoring, adverse drug reaction assessment, and regulatory affairs, often in collaboration with professional teaching hospitals and institutes such as Peter MacCallum Cancer Centre.
The society collaborates with regulatory, clinical, and research organisations to advise on medication safety, therapeutic guidelines, and poison control. Partnerships include Therapeutic Goods Administration, Medsafe, Poisons Information Centre (NSW), and academic consortia spanning University of Western Australia and Swinburne University of Technology. Advocacy efforts have addressed issues raised in inquiries such as state health reviews, and the society provides expert input to guideline panels convened by organizations like Cancer Council Victoria and national immunisation advisory committees. International engagement includes links to European Society for Clinical Pharmacology and Therapeutics and participation in multicentre trials with groups at National Institutes of Health and Wellcome Trust funders.
Category:Medical associations of Australia Category:Medical associations of New Zealand